My Quote Request
No products added yet
6505-01-156-1980
20 Products
NDC00023-0045-15
HYDROXYPROPYL METHYLCELLULOSE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011561980
NSN
6505-01-156-1980
NDC00023-0045-15
HYDROXYPROPYL METHYLCELLULOSE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011561980
NSN
6505-01-156-1980
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V HYDROXYPROPYL METHYLCELLULOSE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: NOT FOR USE WITH SOFT CONTACT LENSES
Related Searches:
6505-00-C99-5685
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
6505-00-C99-5685
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS TOLAZOLINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00083-6722-01
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
NDC00083-6722-01
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS TOLAZOLINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
PRISCOLINE HCL
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
PRISCOLINE HCL
TOLAZOLINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011561984
NSN
6505-01-156-1984
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS TOLAZOLINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
FLURA DROPS
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
FLURA DROPS
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
MFG
KIRKMAN SALES CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.210 MILLIGRAMS SODIUM FULORIDE EQUIVALENT PER 0.2 MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE ORAL SOLUTION USP 24ML SQUEEZE BT
PRIMARY CONTAINER CONTENT QUANTITY: 24.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
SPECIAL FEATURES: WITH CALIBRATED DROPPER TO DELIVER A QUANTITY OF SODIUM FLUORIDE EQUIVALENT TO 1.0 MG OF FLUORIDE ION
Related Searches:
NDC00098-1762-50
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
NDC00098-1762-50
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
MFG
KIRKMAN SALES CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.210 MILLIGRAMS SODIUM FULORIDE EQUIVALENT PER 0.2 MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE ORAL SOLUTION USP 24ML SQUEEZE BT
PRIMARY CONTAINER CONTENT QUANTITY: 24.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
SPECIAL FEATURES: WITH CALIBRATED DROPPER TO DELIVER A QUANTITY OF SODIUM FLUORIDE EQUIVALENT TO 1.0 MG OF FLUORIDE ION
Related Searches:
NDC58223-0684-24
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
NDC58223-0684-24
SODIUM FLUORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505011561998
NSN
6505-01-156-1998
MFG
KIRKMAN SALES CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.210 MILLIGRAMS SODIUM FULORIDE EQUIVALENT PER 0.2 MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE ORAL SOLUTION USP 24ML SQUEEZE BT
PRIMARY CONTAINER CONTENT QUANTITY: 24.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
SPECIAL FEATURES: WITH CALIBRATED DROPPER TO DELIVER A QUANTITY OF SODIUM FLUORIDE EQUIVALENT TO 1.0 MG OF FLUORIDE ION
Related Searches:
NDC00074-0117-01
VITAMIN A C AND D O
NSN, MFG P/N
6505011562012
NSN
6505-01-156-2012
MFG
ABBOTT LABORATORIES DIV ABBOTT DIAGNOSTICS DIVISION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: VITAMIN A C AND D ORAL SOLUTION WITH IRON 50 ML IN DROPPER BOTTLE.
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VITAMIN A C AND D ORAL SOLUTION WITH IRON 50ML
Related Searches:
NDC00071-4160-40
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
NDC00071-4160-40
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYTOCIN INJECTION USP 1ML SYRINGE-NEEDLE UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: EACH ML CONTAINS AN OXYTOCIC ACTIVITY EQUIVALENT TO 10 USP POSTERIOR PITUITARY UNITS; STORAGE AT 2-8 DEG C/35-45 DEG F
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC60793-0416-03
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
NDC60793-0416-03
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
MFG
KING PHARMACEUTICALS INC
Description
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYTOCIN INJECTION USP 1ML SYRINGE-NEEDLE UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: EACH ML CONTAINS AN OXYTOCIC ACTIVITY EQUIVALENT TO 10 USP POSTERIOR PITUITARY UNITS; STORAGE AT 2-8 DEG C/35-45 DEG F
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC61570-0416-03
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
NDC61570-0416-03
OXYTOCIN INJECTION,USP
NSN, MFG P/N
6505011562014
NSN
6505-01-156-2014
MFG
MONARCH PHARMACEUTICALS INC
Description
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYTOCIN INJECTION USP 1ML SYRINGE-NEEDLE UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: EACH ML CONTAINS AN OXYTOCIC ACTIVITY EQUIVALENT TO 10 USP POSTERIOR PITUITARY UNITS; STORAGE AT 2-8 DEG C/35-45 DEG F
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DELESTROGEN
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
DELESTROGEN
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ESTRADIOL VALERATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL VALERATE INJECTION USP 20MG/ML 1ML SYRINGE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PREFILLED; DISPOSABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DELESTROGEN UNIMATIC
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
DELESTROGEN UNIMATIC
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ESTRADIOL VALERATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL VALERATE INJECTION USP 20MG/ML 1ML SYRINGE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PREFILLED; DISPOSABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00003-0343-16
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
NDC00003-0343-16
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011562021
NSN
6505-01-156-2021
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ESTRADIOL VALERATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL VALERATE INJECTION USP 20MG/ML 1ML SYRINGE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PREFILLED; DISPOSABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00069-5420-66
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
NDC00069-5420-66
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
MFG
PFIZER INC. DBA PFIZER
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE PAMOATE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT
Related Searches:
VISTARIL
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
VISTARIL
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
MFG
PFIZER INC. DBA PFIZER
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE PAMOATE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT
Related Searches:
VISTARIL CAPSULES
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
VISTARIL CAPSULES
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011562032
NSN
6505-01-156-2032
MFG
PFIZER INC. DBA PFIZER
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE PAMOATE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT
Related Searches:
NDC00005-5361-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
NDC00005-5361-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.13 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-4835-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
NDC00536-4835-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
MFG
RUGBY GROUP INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.13 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-0371-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
NDC00591-0371-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
MFG
DANBURY PHARMACAL INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.13 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
